Leprosy in HIV infection: a study of three cases.
The course of leprosy in patients with HIV infection has been a controversial issue for a long time. It is still a matter of debate whether the HIV status of an individual has any impact on the natural history of leprosy and response to anti-leprosy treatment. We report here three HIV-positive leprosy cases (two BT and one BB) along with their CD4 counts and HIV staging with anti-leprosy therapeutic response. Both BT cases responded well to conventional WHO MDT (PB) for 6 months, whereas the BB case relapsed 3 months after completion of MDT (MB) for one year. However, he became inactive again following a further one-year course of MDT (MB).
Rath
N
N
Department of Dermatology, Dr Ram Manohar Lohia Hospital, New Delhi 110 001.
Kar
H K
HK
D000328:Adult; D018791:CD4 Lymphocyte Count; D004359:Drug Therapy, Combination; D006678:HIV / Q000254:growth & development*; D015658:HIV Infections / Q000382:microbiology* / Q000473:pathology / Q000821:virology; D006801:Humans; D007194:India; D007916:Lepromin / Q000494:pharmacology; D007917:Leprostatic Agents / Q000627:therapeutic use*; D015439:Leprosy, Borderline / Q000188:drug therapy / Q000473:pathology / Q000821:virology*; D015441:Leprosy, Tuberculoid / Q000188:drug therapy / Q000473:pathology / Q000821:virology*; D008297:Male; D009166:Mycobacterium leprae / Q000254:growth & development*
D007917:Leprostatic Agents; D007916:Lepromin